Relmada Therapeutics, Inc is recruiting patients for the clinical trial to...
This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of REL-1017 once daily (QD) as an adjunctive treatment of Major...
View ArticleMonTa Biosciences ApS is recruiting patients for the clinical trial of of...
The Phase I trial is planned to evaluate safety, tolerability, pharmacokinetics and preliminary efficacy of MBS8(1V270) in subjects with advanced solid tumours. The trial is designed to provide data...
View ArticleThe research company ACADIA Pharmaceuticals Inc is conducting the clinical...
To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain It is planned to include 240 participants. Actual study start date is March 29, 2021. The...
View ArticleProQR Therapeutics is recruiting patients for the clinical trial of...
This is an open-label, dose escalation and double-masked, randomized, controlled study evaluating safety and tolerability of sepofarsen administered via intravitreal (IVT) injection in pediatric...
View ArticleIndependent Public Clinical Hospital No. 4 in Lublin is recruiting patients...
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus. Multicenter randomized, double-blind, placebo-controlled,...
View ArticleElicio Therapeutics started a new clinical trial of ELI-002 immunotherapy for...
This is a Phase 1/2 study to assess the safety and efficacy of ELI-002 immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide [Amph-CpG-7909] plus a mixture of lipid-conjugated...
View ArticleThe company ModernaTX, Inc is commencing the clinical of mRNA-1273 Vaccine in...
The condition is SARS-CoV-2. A new clinical trial is recruiting patients in the following locations: United States. The trial officially began on the April 16, 2021 and is planned to complete on...
View ArticleThe company Alladapt Immunotherapeutics, Inc is commencing a study of the...
A new clinical trial is recruiting patients in the following locations: United States. The condition is Food Allergy. The trial officially began on the April 20, 2021 and is planned to complete on...
View ArticleMamta Parikh is testing Selinexor and Pembrolizumab in patients with...
This phase Ib/II trial finds the best dose of selinexor and its effect with pembrolizumab in treating patients with urothelial carcinoma that are not eligible to receive the chemotherapy drug...
View ArticleErasca, Inc is commencing the clinical trial of ERAS-007 for solid tumors
The scope of this study is: To evaluate the safety and tolerability of ERAS-007 monotherapy administered once weekly (QW) and twice daily-once weekly (BID-QW). To determine the Maximum Tolerated Dose...
View ArticleServicio de Salud Metropolitano Sur Oriente is recruiting patients with...
This study is designed to explore the hypothesis that in patients with a Locally advanced rectal cancer (LARC) treated with a Total neoadjuvant therapy (TNT) strategy based on short course...
View ArticleErasca, Inc is recruiting patients for the clinical trial of ERAS-007 in...
The aim of Study BP41660 is to quantify the amount and concentration of [89Zr]DFO-RO7248824 in the brain with positron emission tomography (PET) following a single sub-pharmacological dose of...
View ArticleSCReN is testing COMIRNATY vaccine in subjects received VAXZEVRIA
The condition is Covid19. A new clinical trial is recruiting patients in the following locations: Spain. The trial officially began on the April 24, 2021 and is planned to complete on April 30, 2022....
View ArticleBausch Health Americas, Inc is evaluating Amiselimod (MT-1303) in Ulcerative...
The condition is Ulcerative Colitis. A new clinical trial is recruiting patients in the following locations: United States. The trial officially began in April 2021 and is planned to complete on...
View ArticleAllakos, Inc is conducting trial of Lirentelimab (AK002) for active...
This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult patients with active...
View ArticleAllakos, Inc is conducting the clinical trial of Lirentelimab (AK002) for...
Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of open-label lirentelimab (AK002) through the OLE Period of the study. It is...
View ArticleTrial of ELI-002 for KRAS Mutated Pancreatic Ductal Adenocarcinoma
This is a Phase 1/2 study to assess the safety and efficacy of ELI-002 immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide [Amph-CpG-7909] plus a mixture of lipid-conjugated...
View ArticleNovo Nordisk A/S is testing semaglutide for non-alcoholic steatohepatitis
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will either...
View ArticleBioNTech SE studies an RNA COVID-19 Vaccine in children
The company BioNTech SE is enrolling patients into the clinical trial investigating Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in...
View ArticleVery high power ablation trial for Atrial Fibrillation
This prospective, randomized, controlled, unblinded, multicenter study aims at comparing procedural time between conventional CLOSE-guided pulmonary vein isolation (PVI) (35W/50W) versus very high...
View ArticleStudy of dalbavancin for Staphylococcus Aureus Bacteremia
This is a Phase 2b clinical study, multicenter, randomized, open-label, assessor-blinded, superiority study. The study will compare dalbavancin to standard of care antibiotic therapy for the...
View ArticleBiohaven Pharmaceuticals, Inc is testing rimegepant for the Acute Treatment...
The condition is Acute Treatment of Migraine. A new clinical trial is recruiting patients in the following locations: United States. The trial officially began on the April 30, 2021 and is planned to...
View ArticleBayer is testing Darolutamide in Prostate Cancer
The purpose of the study is to assess the efficacy and safety of darolutamide in combination with standard androgen deprivation therapy (ADT) in patients with metastatic hormone sensitive prostate...
View ArticleCorvus Pharmaceuticals, Inc is starting a trial of CPI-006 in hospitalized...
This is a phase 3, randomized, placebo controlled, double-blind, multicenter, stratified study of CPI-006 plus standard of care (SOC) versus placebo plus SOC in mild to moderately symptomatic...
View ArticleNational Cancer Institute (NCI) is evaluating Pembrolizumab / CMP-001 for...
This phase II trial studies the effect of pembrolizumab alone or in combination with CMP-001 in treating patients with melanoma that can be treated by surgery (operable). Immunotherapy with monoclonal...
View ArticleAstraZeneca is testing Capivasertib + Palbociclib + Fulvestrant advanced...
AstraZeneca is testing Capivasertib + Palbociclib + Fulvestrant for HR+/HER2- Advanced Breast Cancer A Phase Ib/III Randomised Study of Capivasertib plus Palbociclib and Fulvestrant versus Placebo...
View ArticleStudy of semaglutide in diabetes with chronic kidney disease
This study is to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. We are doing this by looking into how semaglutide works in the kidneys....
View ArticleStudy of (rATG) in patients preparing for bone marrow transplant
Memorial Sloan Kettering Cancer Center is starting a new clinical trial of A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their...
View ArticleBTL Industries Ltd started a new clinical trial for toning of buttocks
The company BTL Industries Ltd is enrolling patients into the clinical trial investigating HIFEM and RF For Toning Of Buttocks. This study will evaluate the clinical efficacy and safety of the BTL-899...
View ArticleA SARS-CoV-2 Infection clinical trial begins in United States
The research company University of Chicago is conducting the clinical trial Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19. The purpose of this study is to compare the risks of...
View ArticleStudy to test Levothyroxine Formulation in Hypothyroid Patients
The purpose of this study is to test a liquid levothyroxine formula and examine if it will lead to improvement in management of thyroid function and if it improves hypothyroid symptoms that patients...
View ArticleClinical trial investigating OCT Guided vs COmplete Pci- in patients with...
The company Azienda Ospedaliera Città della Salute e della Scienza di Torino is enrolling patients into the clinical trial investigating OCT Guided vs COmplete Pci in patieNts With sT Segment...
View ArticleDreamKit Respiratory Effort Signal Validation Study
The research company Philips Clinical & Medical Affairs Global is conducting the clinical trial DreamKit Respiratory Effort Signal Validation. This study has been developed in order to...
View ArticleThe study of VIB7734 for the Treatment of Active Lupus Erythematosus
The company Viela Bio is commencing recruitment for the clinical trial of the A Phase 2 of VIB7734 for the Treatment of Moderate to Severely Active SLE. The condition is Lupus Erythematosus, Systemic....
View ArticleStudy of EDP1867 for moderate atopic dermatitis, moderate psoriasis, and/or...
The company Evelo Biosciences, Inc is enrolling patients into the clinical trial investigating EDP1867 in Healthy Participants and Participants With Moderate Atopic Dermatitis and, Optionally,...
View ArticleThe trial of InterLeukin-7 in lymphopenic patients With COVID-19
Revimmune is recruiting patients for the clinical trial of InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort) (ILIAD-7 BRA). Comparison of the...
View ArticleStudy of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients
AmMax Bio, Inc is recruiting patients for the clinical trial of A Phase 2 Efficacy and Safety Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients. The purpose of this Phase 2,...
View ArticleStudy of FB-401 in patients with atopic dermatitis
Forte Biosciences, Inc is starting a new clinical trial of Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis...
View ArticleLong COVID clinical trial begins in United States.
The research company Resolve Therapeutics is conducting the clinical trial Phase 2 Study of RSLV-132 in Subjects With Long COVID. The purpose of this study is to assess the efficacy, safety and...
View ArticleUrothelial Carcinoma clinical trial begins in United States
The research company Pacific Edge Limited is conducting the clinical trial Efficacy and Utility of Cxbladder Tests in Hematuria Patients. Prospective observational study to validate the performance...
View ArticleStudy of IV NTR-441 solution in healthy volunteers and COVID-19 patients
The company Neutrolis is enrolling patients into the clinical trial investigating Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and...
View ArticleStudy of Isatuximab, bortezomib, lenalidomide, dexamethasone in multiple myeloma
Oslo University Hospital is starting a new clinical trial of REST - Replacing Steroids in the Transplant Ineligble. Newly diagnosed multiple myeloma patients ineligible for HD-ASCT will be included in...
View ArticleSelective C-reactive protein apheresis in ST-elevation myocardial infarction...
Medical University Innsbruck is starting a new clinical trial of CRP Apheresis in STEMI. Background: In patients with acute ST-elevation myocardial infarction (STEMI), the amount of infarcted...
View ArticleStudy of JB-101 to induce operational tolerance in living donor liver
Japan research institute is undertaking a Phase I/II Study to Evaluate the Safety and Efficacy of JB-101(Induced Regulatory T Cell), to Induce Operational Tolerance in Living Donor Liver...
View ArticleStudy of efficacy of CNP-201 in subjects with peanut allergy
COUR Pharmaceutical Development Company, Inc is recruiting patients for the clinical trial of Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-55 With...
View ArticleStudy of OnabotulinumtoxinA (BOTOX) for platysma prominence
The company Allergan is commencing recruitment for the clinical trial of the A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With...
View ArticleRadiostereometry in the Assessment of Knee Prosthesis Study
The company Istituto Ortopedico Galeazzi is commencing recruitment for the clinical trial of the Radiostereometry (Model Based RSA) in the Assessment of Knee Prosthesis Outcome: a...
View ArticleBinaxNOW™ COVID-19 IgG Rapid / BinaxNOW™ COVID-19 Antibody Self Test Study
Abbott Rapid Diagnostics Jena GmbH is recruiting patients for the clinical trial of BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test. Performance evaluation of the BinaxNOW™ COVID-19 IgG...
View ArticleStudy of Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)
The research company LimmaTech Biologics AG is conducting the clinical trial Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V). In this study, the...
View ArticleClinical trial of the Vibrant Capsule vs. Placebo for constipation
Vibrant Ltd is about to start a Prospective, Randomized, Multi-center, Double-Blinded, Clinical Study to Assess the Efficacy and Safety of Vibrant Capsule vs. Placebo, for the Treatment of Chronic...
View Article